Medtech, Pharma, Life Sciences, & Biotech Companies
.
A Path to Investment Success
Discover the Power of
Regulation A+, D 506(c), CF
.
If you are looking to raise up to $75M using Regulation A+, don’t miss out on this opportunity to be part of a financial revolution. Start your journey with Regulation A+, 506c, & CF today and unlock a world of investment potential.
Take a moment and view our fundraising video, white papers, and sample documents.
CPVS™ Resources
Raising up to $75M doesn’t have to be a complicated process. Please review our CPVS™ video presentation, white papers, sample documents, and worksheets to see exactly what we will build for your capital raise.
Take a moment to explore the various resources we have put together for you.
CPVS™ White Papers
Video Presentation on Funding
CPVS™ Sample Documents
CPVS™ Presentation
Watch a Fundraising Presentation
View a sample of a fundraising video presentation that we prepared for a company looking to raise up to $75M using Regulation A+. Learn what Regulation A+ is and how it benefits businesses.
Schedule a FREE CallView Our White Papers
Selling Shareholders Plan for Regulation A+
Discover how shareholders can have a partial liquidity event in Regulation A+.
How to Sell Lead Investors on Funding Your Reg A+
Learn how to sell lead investors on funding your Reg A+.
Corporate Structure
Read about the optimal corporate structure for attracting investment, including Venture Capital, Angel investors, High-Net Worth Individuals, and Reg A+ funding.
Valuation Methods
Read about four startup valuation methods as well as tips for increasing your startup’s valuation when seeking funding.
Capital Planning Valuation Strategy™ Process
Learn about the challenges of facing an uncertain business environment and how a CPVS™ Assessment can benefit your company.
Breaking The Addiction of VC Funding
Discover how you can leave the old model behind and find the final alternative ways to get your startups into the world.
Benefits of A Nasdaq Uplisting and How to Qualify
Discover why Nasdaq is a significant milestone for companies looking to go public and expand access to capital and how you can qualify for it.
CPVS™ Custom Valuation Estimate
Discover how a “fair value” offering price can accurately reflect your company’s revenue potential and financial prospects.
View Our Sample Documents
2022 Reg A+ Filing and Funding Data
Filing information, valuations, and funding data from Reg A+ offerings in FY 2022.
DOWNLOADCapital Planning Valuation Strategy™ (CPVS™) – Sample Form
The exact form you will receive when starting the Capital Planning Valuation Process with us. This secure form is where you will upload the necerssary due dilligence for us to review and create your confidential strategy.
DOWNLOADReg A+ Pricing Analysis
An analysis of price per share data from recently completed Reg A+ offerings.
DOWNLOADMedTech in Reg A+
Offering data and valuations of medtech and healthcare companies using Regulation A+.
DOWNLOADDeal Analysis
VC deals and M&A exits for comparable companies in your industry. See what similar companies have raised and sold for in recent years.
DOWNLOADCPVS™ Custom Pro Forma Cap Table
Our custom pro forma cap table build for your company’s Reg A+ offering.
DOWNLOADCPVS™ Pre- and Post-Valuation
Pre- and Post-Money Valuation of your company based on our pro forma cap table and proposed Reg A+ offering price.
DOWNLOADSelling Shareholders Analysis
Analysis of stock sales, dollar proceeds, and ROI for every selling shareholder in your cap table.
DOWNLOADReg A Val Trend
Review the long-term valuation trend of Reg A+ offerings, including total valuation and average valuation per offering.
DOWNLOADPre-Revenue MedTech Deals
List of pre-revenue medtech companies (or medtechs with less than $1M in revenue) who raised venture capital at a pre-money valuation of $150M or higher.
DOWNLOADPre-Revenue MedTech $5+
List of pre-revenue medtech companies who raised $20M+ in venture capital at an offering price of $5.00 per share or higher.
DOWNLOADInvestor Analytics
Venture capital investment and ownership data of comparable companies in your industry. See how most companies give up control when raising capital under the VC route.
DOWNLOADCapital Raising Assessment
For Medtech, Pharma, Life Sciences, & Biotech Companies
If you are an owner of a medtech, pharma, life sciences, or biotech company and you’re looking to raise up to $75 million without sacrificing control to outside investors, you have to prepare for one of the most important decisions you can make for the future of your business: Raising Capital